AI-Designed COVID Vaccine Passes First Human Trial

First AI-designed 'universal vaccine' tested in humans: U.K. researchers

Read: 2 min A vaccine targeting a broad range of viruses that was designed using artificial intelligence had a “modest” effect on immune systems in a small, early trial, according to a new study. The trial marks the first time a vaccine whose active ingredient was entirely designed by AI has been tested in humans, researchers at the University of Cambridge in the U.K. said on Friday. The experimental jab is intended to be a “universal vaccine” w…

Breakthrough in Vaccine Science: AI-Designed Universal Coronavirus Shot Shows Safety in First Human Trial

AI-designed universal coronavirus vaccine shows safety and immune response in first human trial, targeting multiple coronaviruses including SARS and MERS.

New AI-developed vaccine could protect against mutations and thousands of viruses

Cambridge researchers used AI to design a 'universal vaccine' that may protect against thousands of viruses and future mutations; first human trial found it safe and able to trigger immune response, raising hopes for pandemic prevention

AI-designed vaccine clears first human trial, but questions remain

Researchers hope AI-designed universal vaccines could one day provide broader protection against entire families of viruses. LONDON: A vaccine designed entirely by artificial intelligence has passed its first test in humans, marking a milestone in efforts to develop broader protection against future virus outbreaks. Researchers at the University of Cambridge said the experimental vaccine is the first whose active ingredient, or antigen, was crea…

AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery

The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side effects.